SCHEMBL16379331

SCHEMBL16379331

C[C@H](C(=O)O)[C@H](O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
AKR1C3 P42330 2/20 0.49
AKR1C2 P52895 2/20 0.49
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MMP7 P09237 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
ACP3 P15309 1/20 0.44
GRM8 O00222 1/20 0.43
GRM4 Q14833 1/20 0.43
FFAR1 O14842 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16379328 1.00 CES2 (0.50) CES2CES1AKR1C3AKR1C2PSEN1
SCHEMBL1797371 0.79 AKR1C3 (0.65) CES2CES1AKR1C3AKR1C2PSEN1
SCHEMBL5698990 0.79 CES2 (0.48) CES2CES1AKR1C3AKR1C2ACP3
SCHEMBL9668161 0.79 PDE2A (0.56) CES2CES1AKR1C3AKR1C2ACP3
SCHEMBL4967991 0.79 NR1I2 (0.53) CES2CES1AKR1C3AKR1C2ACP3
SCHEMBL5018968 0.79 NR1I2 (0.53) CES2CES1AKR1C3AKR1C2ACP3
SCHEMBL836794 0.78 CES2 (0.46) CES2CES1AKR1C3AKR1C2PSEN1
SCHEMBL5018989 0.78 CES2 (0.46) CES2CES1AKR1C3AKR1C2PSEN1
SCHEMBL836793 0.78 CES2 (0.46) CES2CES1AKR1C3AKR1C2PSEN1
SCHEMBL3640672 0.78 CES2 (0.46) CES2CES1AKR1C3AKR1C2PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933018-B2 Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2015-01-13 US disclosed